Skip to main content

Research Repository

Advanced Search

IL-7 is superior to IL-2 for ex vivo expansion of tumourspecific CD4 + T cells

Caserta, Stefano; Alessi, Patrizia; Basso, Veronica; Mondino, Anna

Authors

Patrizia Alessi

Veronica Basso

Anna Mondino



Abstract

It is well established that tumours hinder both natural and vaccine-induced tumourspecific CD4 + T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional tolerance and enhance anti-tumour protective responses. While protocols suitable for the expansion of cytotoxic CD8 + T cells are currently available, data on tumour-specific CD4 + T cells remain scarce.We report here that CD4 + T cells sensitized to tumour-associated Ag in vivo, proliferate in vitro in response to IL-7 without the need for exogenous Ag stimulation and accumulate several folds while preserving a memory-like phenotype. Both cell proliferation and survival accounts for the outgrowth of tumoursensitized T cells among other memory and naive lymphocytes following exposure to IL-7. Also IL-2, previously used to expand anti-tumour CTL, promotes tumour-specific CD4 + T-cell accumulation. However, IL-7 is superior to IL-2 at preserving lymphocyte viability, in vitro and in vivo, maintaining those properties, that are required by helper CD4 + T cells to confer therapeutic efficacy upon transplantation in tumour-bearing hosts. Together our data support a unique role for IL-7 in retrieving memory-like CD4 + T cells suitable for adoptive T-cell therapy. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.

Citation

Caserta, S., Alessi, P., Basso, V., & Mondino, A. (2010). IL-7 is superior to IL-2 for ex vivo expansion of tumourspecific CD4 + T cells. European journal of immunology, 40(2), 470-479. https://doi.org/10.1002/eji.200939801

Journal Article Type Article
Acceptance Date Nov 12, 2009
Online Publication Date Nov 30, 2009
Publication Date Feb 1, 2010
Deposit Date Jun 28, 2018
Journal European Journal of Immunology
Print ISSN 0014-2980
Electronic ISSN 1521-4141
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 40
Issue 2
Pages 470-479
DOI https://doi.org/10.1002/eji.200939801
Keywords Adoptive T‐cell therapy; Cytokines; T helper cells; Tumour immunology
Public URL https://hull-repository.worktribe.com/output/620565
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200939801